
The UK has officially approved Mounjaro, a revolutionary weight loss injection, but its steep £300-per-month price has raised eyebrows. Marketed as a potential game-changer in obesity treatment, the drug—developed by pharmaceutical giant Eli Lilly—contains tirzepatide, a compound shown to suppress appetite and regulate blood sugar.
How Does Mounjaro Work?
Unlike traditional weight loss methods, Mounjaro mimics hormones that control hunger and insulin levels. Clinical trials suggest users could shed up to 20% of their body weight, making it a tantalising option for those struggling with obesity.
NHS Access in Question
While private prescriptions are already available, NHS rollout remains uncertain. Health experts warn that the drug’s cost could strain budgets, leaving many to wonder: Will this treatment only be for those who can afford it?
Side Effects and Considerations
Common side effects include nausea and digestive issues, though severe complications are rare. Doctors urge patients to consult healthcare providers before starting treatment.